CSS
VIVO

Cubist Systematic Strategies’s Meridian Bioscience Inc VIVO Stock Holding History

Cubist Systematic Strategies’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-49,186
Closed -$1.5M – 4968
2022
Q2 		$1.5M Buy
49,186
+4,216
+9% +$114K 0.01% 2127
2022
Q1 		$1.17M Buy
44,970
+4,548
+11% +$108K 0.01% 1921
2021
Q4 		$825K Buy
+40,422
New +$775K 0.01% 2067
2021
Q1 		– Sell
-48,380
Closed -$904K – 3023
2020
Q4 		$904K Buy
48,380
+5,611
+13% +$105K 0.01% 1443
2020
Q3 		$726K Buy
42,769
+21,627
+102% +$420K 0.01% 1516
2020
Q2 		$492K Sell
21,142
-1,180
-5% -$17.1K 0.01% 1598
2020
Q1 		$188K Sell
22,322
-9,314
-29% -$78.4K 0.01% 1754
2019
Q4 		$309K Buy
31,636
+11,478
+57% +$108K 0.01% 1826
2019
Q3 		$191K Sell
20,158
-11,789
-37% -$124K ﹤0.01% 1794
2019
Q2 		$380K Buy
+31,947
New +$385K 0.01% 1656
2019
Q1 		– Sell
-11,435
Closed -$199K – 2471
2018
Q4 		$199K Buy
+11,435
New +$195K 0.01% 1546
2018
Q2 		– Sell
-13,163
Closed -$187K – 2131
2018
Q1 		$187K Buy
+13,163
New +$195K 0.01% 1429

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cubist Systematic Strategies's VIVO Position: Q3 2022 in Review

Cubist Systematic Strategies sold out of Meridian Bioscience Inc (VIVO) in Q3 2022, closing a stake of 49,186 shares — an estimated $1.5M sold.

Cubist Systematic Strategies first reported a position in VIVO in Q1 2018 and held it in 12 quarters. The position peaked at $1.5M in Q2 2022. 203 funds tracked by Wall St. Rank hold VIVO as of Q3 2022.

  • Cubist Systematic Strategies reported no remaining Meridian Bioscience Inc position as of Q3 2022 after selling out during the quarter.
  • Cubist Systematic Strategies sold 49,186 Meridian Bioscience Inc shares in Q3 2022, an estimated $1.5M.
  • Cubist Systematic Strategies first reported a position in Meridian Bioscience Inc in Q1 2018 and held it in 12 quarters.
  • Cubist Systematic Strategies's Meridian Bioscience Inc position peaked at $1.5M in Q2 2022.
  • 203 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2022.

Based on Cubist Systematic Strategies's 13F filing for Q3 2022, filed 14 Nov 2022.